These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


135 related items for PubMed ID: 9300318

  • 1. Long-term beta 1-adrenergic blockade restores adrenomedullary activity in primary hypertension.
    Jacobs MC, Lenders JW, Smits P, Willemsen JJ, Tack C, Thien T.
    J Cardiovasc Pharmacol; 1997 Sep; 30(3):338-42. PubMed ID: 9300318
    [Abstract] [Full Text] [Related]

  • 2. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH, Davies RA, Fourney A.
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [Abstract] [Full Text] [Related]

  • 3. Chronic alpha-1-adrenergic blockade increases sympathoneural but not adrenomedullary activity in patients with essential hypertension.
    Jacobs MC, Lenders JW, Willemsen JJ, Thien T.
    J Hypertens; 1995 Dec; 13(12 Pt 2):1837-41. PubMed ID: 8903663
    [Abstract] [Full Text] [Related]

  • 4. Adrenomedullary secretion of epinephrine is increased in mild essential hypertension.
    Jacobs MC, Lenders JW, Willemsen JJ, Thien T.
    Hypertension; 1997 Jun; 29(6):1303-8. PubMed ID: 9180633
    [Abstract] [Full Text] [Related]

  • 5. Impaired vasodilation during long-term beta 1-selective beta-blockade in hypertensive patients.
    Lenders JW, de Boo T, Lemmens WA, Reyenga J, Thien T.
    Clin Pharmacol Ther; 1988 Aug; 44(2):195-201. PubMed ID: 3396263
    [Abstract] [Full Text] [Related]

  • 6. Epinephrine-induced enhancement of sympathetic activity in humans: inhibition by nonselective as well as beta 1-selective beta-adrenoceptor blockade.
    van den Meiracker AH, Man in 't Veld AJ, Boomsma F, Blankestijn PJ, Schalekamp MA.
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):610-7. PubMed ID: 1691392
    [Abstract] [Full Text] [Related]

  • 7. Effects of mental and physical stress on plasma catecholamine levels before and after beta-adrenoceptor blocker treatment.
    Paran E, Neumann L, Cristal N.
    Eur J Clin Pharmacol; 1992 Apr; 43(1):11-5. PubMed ID: 1354617
    [Abstract] [Full Text] [Related]

  • 8. Propranolol and atenolol inhibit norepinephrine spillover rate into plasma in conscious spontaneously hypertensive rats.
    Keeton TK, Biediger AM.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):47-55. PubMed ID: 1685557
    [Abstract] [Full Text] [Related]

  • 9. Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.
    McLeod AA, Brown JE, Kuhn C, Kitchell BB, Sedor FA, Williams RS, Shand DG.
    Circulation; 1983 May; 67(5):1076-84. PubMed ID: 6299612
    [Abstract] [Full Text] [Related]

  • 10. Home blood pressure monitoring and changes in plasma catecholamines during once or twice daily treatment with atenolol in patients with mild hypertension.
    McGrath BP, Beilin LJ, Schofield T, Benedict CR, Barker NP, Cooper R.
    Aust N Z J Med; 1979 Aug; 9(4):374-81. PubMed ID: 389223
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH, Man in't Veld AJ, Boomsma F, Fischberg DJ, Molinoff PB, Schalekamp MA.
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [Abstract] [Full Text] [Related]

  • 12. Effects of atenolol and hydrochlorothiazide on blood pressure and plasma catecholamines in essential hypertension.
    Myers MG, de Champlain J.
    Hypertension; 1983 Oct; 5(4):591-6. PubMed ID: 6862582
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of low- and high-intensity lower body negative pressure on noradrenaline and adrenaline kinetics in humans.
    Jacobs MC, Goldstein DS, Willemsen JJ, Smits P, Thien T, Lenders JW.
    Clin Sci (Lond); 1996 May; 90(5):337-43. PubMed ID: 8665770
    [Abstract] [Full Text] [Related]

  • 14. A test of the "epinephrine hypothesis" in humans.
    Goldstein DS, Golczynska A, Stuhlmuller J, Holmes C, Rea RF, Grossman E, Lenders J.
    Hypertension; 1999 Jan; 33(1):36-43. PubMed ID: 9931079
    [Abstract] [Full Text] [Related]

  • 15. Increased plasma free dopamine after treatment with atenolol and oxprenolol in essential hypertension.
    Kjeldsen SE, Eide I, Aakesson I, Amundsen R, Eriksen IL, Leren P.
    Acta Med Scand; 1983 Jan; 214(5):367-71. PubMed ID: 6660046
    [Abstract] [Full Text] [Related]

  • 16. Hemodynamic effects of celiprolol in essential hypertension.
    Frohlich ED, Ketelhut R, Kaesser UR, Losem CJ, Messerli FH.
    Am J Cardiol; 1991 Aug 15; 68(5):509-14. PubMed ID: 1678580
    [Abstract] [Full Text] [Related]

  • 17. Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH, Man in 't Veld AJ, van Eck HJ, Boomsma F, Schalekamp MA.
    Circulation; 1988 Oct 15; 78(4):957-68. PubMed ID: 3048776
    [Abstract] [Full Text] [Related]

  • 18. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.
    Hiatt WR, Wolfel EE, Stoll S, Nies AS, Zerbe GO, Brammell HL, Horwitz LD.
    Clin Pharmacol Ther; 1985 Jan 15; 37(1):2-6. PubMed ID: 2856902
    [Abstract] [Full Text] [Related]

  • 19. Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients.
    Simon G, Franciosa JA, Gimenez HJ, Cohn JN.
    Hypertension; 1981 Jan 15; 3(2):262-8. PubMed ID: 6111532
    [Abstract] [Full Text] [Related]

  • 20. Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
    Chang PC, van Veen S, van der Krogt JA, Vermeij P, van Brummelen P.
    J Cardiovasc Pharmacol; 1988 Sep 15; 12(3):317-22. PubMed ID: 2464104
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.